{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:55:14Z","timestamp":1762430114233},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T00:00:00Z","timestamp":1163721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2007,8,30]]},"DOI":"10.1007\/s11255-006-9125-2","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T09:05:29Z","timestamp":1163667929000},"page":"859-863","source":"Crossref","is-referenced-by-count":26,"title":["The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis"],"prefix":"10.1007","volume":"39","author":[{"given":"Cuneyt","family":"Ozden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozdem Levent","family":"Ozdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozer","family":"Guzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selda","family":"Seckin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Memis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,17]]},"reference":[{"key":"9125_CR1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(17)38491-4","volume":"145","author":"JE Oesterling","year":"1991","unstructured":"Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145:907\u2013923","journal-title":"J Urol"},{"key":"9125_CR2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-5347(17)37402-5","volume":"147","author":"F Labrie","year":"1992","unstructured":"Labrie F, Dupont A, Suburu R, et al. (1992) Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 147:846\u2013851","journal-title":"J Urol"},{"key":"9125_CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","volume":"147","author":"MC Benson","year":"1992","unstructured":"Benson MC, Whang IS, Pantuck A, et al. (1992) Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147:815\u2013816","journal-title":"J Urol"},{"key":"9125_CR4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","volume":"151","author":"WJ Catalona","year":"1994","unstructured":"Catalona WJ, Richie JP, Ahmann FR, et al. (1994) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: result of a multicenter clinical trial of 6,630 men. J Urol 151:1283\u20131290","journal-title":"J Urol"},{"key":"9125_CR5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","volume":"270","author":"JE Oesterling","year":"1993","unstructured":"Oesterling JE, Jacobsen SJ, Chute CG, et al. (1993) Serum prostate specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 270:860\u2013864","journal-title":"JAMA"},{"key":"9125_CR6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","volume":"147","author":"MC Benson","year":"1992","unstructured":"Benson MC, Whang IS, Pantuck A, et al. (1992) Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147:815\u2013816","journal-title":"J Urol"},{"key":"9125_CR7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, et al. (1997) Inflammation in benign prostatic hyperplasia: Correlation with prostate specific antigen value. J Urol 157:1301\u20131303","journal-title":"J Urol"},{"key":"9125_CR8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"2000","unstructured":"Schatteman PH, Hoekx L, Wyndaele JJ, et al. (2000) Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis. Eur Urol 37:404\u2013412","journal-title":"Eur Urol"},{"key":"9125_CR9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5347(17)56980-3","volume":"121","author":"PW Kohnen","year":"1979","unstructured":"Kohnen PW, Drach GW (1979) Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 121:755\u2013760","journal-title":"J Urol"},{"key":"9125_CR10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00000478-199210000-00008","volume":"16","author":"W Blumenfeld","year":"1992","unstructured":"Blumenfeld W, Tucci S, Narayan P (1992) Incidental lymphocytic prostatitis: Selective involvement with nonmalignant glands. Am J Surg Pathol 16:975\u2013981","journal-title":"Am J Surg Pathol"},{"key":"9125_CR11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1464-410X.1971.tb12050.x","volume":"43","author":"EO Odunjo","year":"1971","unstructured":"Odunjo EO, Elebute EA (1971) Chronic prostatitis in benign prostatic hyperplasia. Br J Urol 43: 333\u2013337","journal-title":"Br J Urol"},{"key":"9125_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajcp\/49.3.347","volume":"49","author":"JE McNeal","year":"1968","unstructured":"McNeal JE (1968) Regional morphology and pathology of the prostate. Am J Clin Pathol 49:347\u2013357","journal-title":"Am J Clin Pathol"},{"key":"9125_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","volume":"282","author":"JN Krieger","year":"1999","unstructured":"Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236\u2013237","journal-title":"JAMA"},{"key":"9125_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11255-005-1662-6","volume":"38","author":"MN Battikhi","year":"2006","unstructured":"Battikhi MN, Ismail H, Battikhi Q (2006) Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer. Int Urol Nephrol 38:21\u201326","journal-title":"Int Urol Nephrol"},{"key":"9125_CR15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000472983","volume":"14","author":"J Morote-Robles","year":"1988","unstructured":"Morote-Robles J, Ruibal-Morell A, Palou-Reudorta J, et al. (1988) A: Clinical behavior of prostatic acid phosphatase: A comparative study. Eur Urol 14:360\u2013366","journal-title":"Eur Urol"},{"key":"9125_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/pros.2990250206","volume":"25","author":"Y Hasui","year":"1994","unstructured":"Hasui Y, Marutsuka K, Asada Y, et al. (1994) Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 25:91\u201396","journal-title":"Prostate"},{"key":"9125_CR17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","volume":"84","author":"JC Nickel","year":"1999","unstructured":"Nickel JC, Downey J, Young I, et al. (1999) Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia. BJU Int 84:976\u2013981","journal-title":"BJU Int"},{"key":"9125_CR18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000020190","volume":"37","author":"J Morote","year":"2000","unstructured":"Morote J, Lopez M, Encabo G, et al. (2000) Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 37:537\u2013540","journal-title":"Eur Urol"},{"key":"9125_CR19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(00)00519-7","volume":"55","author":"K Okada","year":"2000","unstructured":"Okada K, Kojima M, Naya Y, et al. (2000) Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 55:892\u2013898","journal-title":"Urology"},{"key":"9125_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11255-004-0845-x","volume":"36","author":"BH Gumus","year":"2004","unstructured":"Gumus BH, Nese N, Gunduz MI, et al. (2004) Does asymptomatic inflammation increase PSA? A histopathological study comparing benign and malignant tissue biopsy specimens. Int Urol Nephrol 36:549\u2013553","journal-title":"Int Urol Nephrol"},{"key":"9125_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11255-005-3618-2","volume":"38","author":"JT Anim","year":"2006","unstructured":"Anim JT, Kehinde EO, Prasad A, et al. (2006) Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men. Int Urol Nephrol 38:27\u201332","journal-title":"Int Urol Nephrol"},{"key":"9125_CR22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.urology.2004.08.060","volume":"64","author":"LH Simardi","year":"2004","unstructured":"Simardi LH, Tobias-MacHado M, Kappaz GT, et al (2004) Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study. Urology 64:1098\u20131101","journal-title":"Urology"},{"key":"9125_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000071839","volume":"71","author":"O Yaman","year":"2003","unstructured":"Yaman O, Gogus C, Tulunay O, Tokatli Z, Ozden E (2003) Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation. Urol Int 71:160\u2013164","journal-title":"Urol Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-006-9125-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9125-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:55:19Z","timestamp":1559375719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-006-9125-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,17]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8,30]]}},"alternative-id":["9125"],"URL":"https:\/\/doi.org\/10.1007\/s11255-006-9125-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,17]]}}}